Patents
More topics under "C07D - Heterocyclic compounds" (1,537,440)
C07D 201 - Preparation, separation, purification, or stabilisation of unsubstituted lactams (2,192)
C07D 203 - Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom (1,097)
C07D 205 - Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom (6,868)
C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865)
C07D 219 - Heterocyclic compounds containing acridine or hydrogenated acridine ring systems (2,120)
C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups (10,931)
C07D 223 - Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom (8,732)
C07D 225 - Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom (1,649)
C07D 227 - Heterocyclic compounds containing rings having one nitrogen atom as the only ring hetero atom, according to more than one of groups (473)
C07D 229 - Heterocyclic compounds containing rings of less than five members having two nitrogen atoms as the only ring hetero atoms (515)
C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550)
C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325)
C07D 237 - Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings (8,468)
C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673)
C07D 243 - Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms (5,961)
C07D 245 - Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms (898)
C07D 247 - Heterocyclic compounds containing rings having two nitrogen atoms as the only ring hetero atoms, according to more than one of groups (239)
C07D 249 - Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms (17,749)
C07D 251 - Heterocyclic compounds containing 1,3,5-triazine rings (10,913)
C07D 253 - Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group (2,967)
C07D 255 - Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups (739)
C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms (9,612)
C07D 259 - Heterocyclic compounds containing rings having more than four nitrogen atoms as the only ring hetero atoms (488)
C07D 261 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings (11,459)
C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978)
C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132)
C07D 267 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms (2,022)
C07D 269 - Heterocyclic compounds containing rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms according to more than one of groups (111)
C07D 271 - Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms (7,144)
C07D 273 - Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups (2,368)
C07D 275 - Heterocyclic compounds containing 1, 2-thiazole or hydrogenated 1,2-thiazole rings (4,972)
C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
C07D 279 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms (5,149)
C07D 281 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms (1,924)
C07D 283 - Heterocyclic compounds containing rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms, according to more than one of groups (102)
C07D 285 - Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups (9,964)
C07D 291 - Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms (1,087)
C07D 293 - Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms (553)
C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
C07D 301 - Preparation of oxiranes (10,136)
C07D 303 - Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom (12,512)
C07D 305 - Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms (5,442)
C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
C07D 309 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings (12,815)
C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127)
C07D 313 - Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom (3,580)
C07D 315 - Heterocyclic compounds containing rings having one oxygen atom as the only ring hetero atom according to more than one of groups (1,360)
C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms (18,224)
C07D 319 - Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms (10,283)
C07D 321 - Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups (2,079)
C07D 323 - Heterocyclic compounds containing more than two oxygen atoms as the only ring hetero atoms (1,581)
C07D 325 - Heterocyclic compounds containing rings having oxygen as the only ring hetero atom according to more than one of groups (168)
C07D 327 - Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms (2,428)
C07D 329 - Heterocyclic compounds containing rings having oxygen and selenium or oxygen and tellurium atoms as the only ring hetero atoms (47)
C07D 331 - Heterocyclic compounds containing rings of less than five members, having one sulfur atom as the only ring hetero atom (456)
C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
C07D 335 - Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom (4,725)
C07D 337 - Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom (875)
C07D 339 - Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms (3,352)
C07D 341 - Heterocyclic compounds containing rings having three or more sulfur atoms as the only ring hetero atoms (281)
C07D 343 - Heterocyclic compounds containing rings having sulfur and selenium or sulfur and tellurium atoms as the only ring hetero atoms (52)
C07D 345 - Heterocyclic compounds containing rings having selenium or tellurium atoms as the only ring hetero atoms (419)
C07D 347 - Heterocyclic compounds containing rings having halogen atoms as ring hetero atoms (38)
C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963)
C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
C07D 411 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms (2,465)
C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
C07D 415 - Heterocyclic compounds containing the thiamine skeleton (90)
C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
C07D 419 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms (1,431)
C07D 421 - Heterocyclic compounds containing two or more hetero rings, at least one ring having selenium, tellurium, or halogen atoms as ring hetero atoms (480)
C07D 451 - Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.02,4] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof (5,273)
C07D 453 - Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids (5,704)
C07D 455 - Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine (2,122)
C07D 457 - Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula: , e.g. lysergic acid (836)
C07D 459 - Heterocyclic compounds containing benz [g] indolo [2, 3-a] quinolizine ring systems, e.g. yohimbine; 16, 18-lactones thereof, e.g. reserpic acid lactone (97)
C07D 461 - Heterocyclic compounds containing indolo [3, 2, 1-d, e] pyrido [3, 2, 1-i, j] [1, 5]-naphthyridine ring systems, e.g. vincamine (286)
C07D 463 - Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (613)
C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
C07D 473 - Heterocyclic compounds containing purine ring systems (11,932)
C07D 475 - Heterocyclic compounds containing pteridine ring systems (2,718)
C07D 477 - Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (2,484)
C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
C07D 489 - Heterocyclic compounds containing 4ah-8, 9 c- iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: (2,334)
C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
C07D 493 - Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system (17,376)
C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
C07D 497 - Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms (1,069)
C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
C07D 499 - Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (3,448)
C07D 501 - Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (7,574)
C07D 503 - Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (648)
C07D 505 - Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (556)
C07D 507 - Heterocyclic compounds containing a condensed beta-lactam ring system, not provided for by groups , or; Such ring systems being further condensed (161)
C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120)
C07D 515 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (877)
C07D 517 - Heterocyclic compounds containing in the condensed system at least one hetero ring having selenium, tellurium, or halogen atoms as ring hetero atoms (452)
C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041)
C07D 521 - Heterocyclic compounds containing unspecified hetero rings (16,203)
Patents for C07D - Heterocyclic compounds (10,420)
06/1985
06/12/1985EP0144285A1 Lactones with pesticidal activity for veterinary or agricultural use
06/12/1985EP0144032A2 Cephalosporins and process for their preparation
06/11/1985US4522806 Oral compositions for hexetidine and zinc salts for the synergistic inhibition of dental plaque
06/05/1985EP0143658A2 Improvements in or relating to cephalosporin derivatives
06/05/1985EP0143465A2 Novel halonitriles and their preparation
06/04/1985CA1188306A1 Process for the preparation of 1-alkyl-or 1,4-dialkyl- 1h-pyrrole-2-acetic acid esters
05/1985
05/28/1985US4520022 Substituted vinyl cephalosporins
05/21/1985CA1187501A1 ¬2-(l-piperidinyl)-phenyl|-phenyl methanone
05/15/1985EP0140949A1 Novel cephalosporin derivatives, pharmaceutical compositions containing the same, their use in therapy as antibiotics and a process for the preparation of the novel compounds
05/07/1985CA1186682A1 Crystalline salts of cefodizim and a process for their preparation
04/1985
04/23/1985US4513134 Reacting 3-halomethylbutenoate derivatives of thiazolinoazetidinone with aqueous acid solution
04/17/1985EP0137534A2 One-pot process for preparation of 7beta-amino- and 7beta-acylamino- 3-substituted methyl-3-cephem-4-carboxylic acid derivatives and process for deoxygenation of 7beta-acylamino-3-cephem-4-carboxylic acid 1-oxide derivatives
04/17/1985EP0137442A2 Cephalosporin derivatives and process for their preparation
04/17/1985EP0137441A2 Cephalosporin derivatives and process for their preparation
04/17/1985EP0137440A2 Cephalasporin derivatives and process for their preparation
04/16/1985CA1185599A1 Cephalosporin derivatives
04/11/1985EP0120054A4 Purified hematoporphyrin derivative for diagnosis and treatment of tumors, and method.
04/10/1985EP0136737A1 1-(4'Alkylsulfonylphenyl)-2-amino-1,3-propanediol N-substituted derivatives
04/10/1985EP0136647A2 Cyclohexenon derivatives, process for their preparation and their use in combating undesirable plant growth
04/03/1985EP0136266A2 7-Beta-acylamido-3-cephem-4-carboxylic-acid esters, process for their preparation, pharmaceutical compositions and their application
04/02/1985US4508725 Esters of 3-(3-substituted-amino-2-hydroxypropoxy)-4-substituted-1,2,5-thiadiazole derivatives
03/1985
03/27/1985EP0135258A2 Improvements in or relating to a crystalline 7-(R)-amino-3-(1-pyridiniummethyl)-ceph-3-em-4-carboxylate
03/20/1985EP0134502A1 Heparan sulfate fractions, process for their preparation and compositions thereof
03/12/1985US4504477 Cephalosporin antibiotics
03/05/1985US4503076 Vasodilator compound and pharmaceutical compositions therefrom
02/1985
02/26/1985US4501741 Cephalosporin antibiotics
02/19/1985CA1182810A1 Crystalline antibiotics salt
02/05/1985US4497809 Cephalosporin derivatives
01/1985
01/30/1985EP0132308A1 Biosynthetic 2,5-diketogluconic acid reductase, processes, recombinant cells and expression vectors for its production, and its use in preparing 2-keto-L-gulonic acid
01/29/1985US4496565 Hypotensive agents
01/29/1985CA1181741A1 Water soluble derivatives of cephalexin and process for their preparation
01/22/1985US4495233 Corrugating elements
01/22/1985US4495108 Process for preparing dialkyl propanediimidate dihydrohalides
01/15/1985CA1181077A1 Imidazole hydrazone derivatives production thereof and use in medicine
12/1984
12/25/1984US4490370 Bactericides
12/12/1984EP0128029A2 Cephalosporin ester derivatives, their production and use
12/11/1984US4487965 Trans-3-(4'-tert.-Butylcyclohex-1'yl)-2-methyl-1-dialkylaminopropanes, their preparation and their use as drugs
12/06/1984WO1984004747A1 Cephem compounds
12/05/1984EP0127543A2 Antibiotic cephalosporin derivatives, process for their preparation and pharamceutical compositions containing them
11/1984
11/21/1984EP0125576A2 Process for the preparation of cephalosporins
11/20/1984CA1178289A1 Process for the preparation of n-¬2-¬¬¬5- (dimethylamino)-methyl-2- furanyl|methyl|thio|ethyl|-n'-methyl-2-nitro- 1,1-ethenediamine
11/20/1984CA1178271A1 Cephalosporin derivatives and process for their preparation
11/20/1984CA1178270A1 Aminohydroxyphenyl compounds, processes for their manufacture, pharmaceutical preparations containing these compounds, and the use of these compounds
11/14/1984EP0124889A2 Process for the preparation of cephalosporins
11/13/1984US4482710 Process for preparing 3-alkoxymethylcephalosporin derivatives
11/13/1984CA1177755A1 Pharmaceutical composition having antiphlogistic, antipyretic and analgesic activity
11/07/1984EP0123830A2 Novel process for the preparation of aminonitriles useful for the preparation of herbicides
11/06/1984CA1177491A1 Process for the preparation of 2-¬¬¬5- (dimethylamino)methyl-2-furanylmethylthio furanyl|methyl|thio|ethaneamine ethaneamine
10/1984
10/30/1984CA1177064A1 Cephalosporin derivatives, their production and their uses
10/25/1984WO1984004096A1 Novel cephalosporin derivatives, pharmaceutical compositions containing the same, their use in therapy as antibiotics and a process for the preparation of the novel compounds
10/24/1984EP0122585A2 Crystalline form of ceftazidim
10/24/1984EP0122584A2 Crystalline form of ceftazidim
10/23/1984US4479002 Chemical intermediates for insecticides, pesticides
10/23/1984US4478844 Bradycardiac or analgesic 2-(N-(thienyl-2-methyl)-N-(2-fluoro-6-methyl-phenyl)-amino)-2-imidazoline and salts thereof
10/17/1984EP0122158A2 Improvements in or relating to benzothienyl cephalosporin antibiotics
10/16/1984US4477660 Isomerization by reacting with an amine; oxacephalosporins
10/16/1984US4477447 7-Acylaminocephalosporanic acid derivatives
10/16/1984CA1176240A1 Cephem compounds, processes for preparation thereof and pharmaceutical composition comprising the same
10/09/1984US4476123 Antibiotic derivatives, derived from cephalosporins with thiazolyl substituents, pharmaceutical preparations and salts thereof
10/03/1984EP0120054A1 Purified hematoporphyrin derivative for diagnosis and treatment of tumors, and method.
10/02/1984CA1175432A1 N-oxacyclyl-alkylpiperidine derivatives, process for their preparation, pharmaceutical products containing them, and their use
10/02/1984CA1175417A1 Thiomethyl cephalosporins
09/1984
09/26/1984EP0119799A1 Process for preparing dialkyl propanediimidate dihydrohalides
09/25/1984US4473567 Substituted-imidazolidinyl-3-chloro-3-cephem-4-carboxylic acid
09/18/1984US4472421 Shampoo
09/12/1984EP0118196A1 Process for the manufacture of highly crystalline sodium cefoperazone
09/11/1984US4471115 Water soluble derivatives of cephalex and process for their preparation
09/11/1984US4470989 Neuroleptic n-oxacyclyl-alkylpiperidine derivatives
09/11/1984US4470983 Cephalosporin derivatives
09/05/1984EP0117651A2 Process for the preparation of cephalosporins
09/04/1984CA1173830A1 Aminocyclopentane alkenoic acids and esters and their preparation and pharmaceutical formulation
09/04/1984CA1173824A1 Process for the preparation of solutions of 7- aminocephalosporanic acids
08/1984
08/28/1984US4468514 Preparation of 3-bromocephalosporins from thiazoline azetidinones
08/21/1984US4467086 Cephalosporin antibiotic
08/14/1984CA1172627A1 Process for producing cephalosporin antibiotics, and novel intermediates for use in such process and their production
08/08/1984EP0115413A1 +/- 2-(Phenethyl)-5-((3,4-methylenedioxy)-alpha-hydroxybenzyl)-pyrrolidines, pharmaceutical compositions containing them, processes for their production and intermediates therefor
08/01/1984EP0114758A1 +/- 2-((3,4-Methylenedioxy)phenethyl)-5-((3-carboxamido-4-hydroxy)-alpha-hydroxybenzyl)pyrrolidines, pharmaceutical compositions containing them, process for their production and intermediates therefor
07/1984
07/31/1984CA1171876A1 Substitution product of glycine, method of preparation thereof and pharmaceutical compositions therefrom
07/18/1984EP0113568A2 Intermediates for the preparation of ceftazidine, and process for their preparation
07/10/1984CA1170652A1 Cephalosporins, processes for their preparation and pharmaceutical compositions containing them
07/05/1984WO1984002525A1 Esters of 3-(3-substituted-amino-2-hydroxypropoxy)-4-substituted-1,2,5-thiadiazole derivatives
07/04/1984EP0112550A2 Crystalline acid addition salts of cephalosporins and process for their preparation
07/03/1984US4458070 Storage stability
07/03/1984US4457929 Bactericides
06/1984
06/27/1984EP0112135A2 Bromination of cephalosporins
06/27/1984EP0111935A2 Cephalosporin derivatives and process for their preparation
06/27/1984EP0111934A2 Cephalosporin derivatives and process for their preparation
06/26/1984US4456769 One-step reaction of an imidoester with hydrazine hydrate
06/26/1984US4456753 Controlled addition of acetone to water/acetone/sodium cefoperazone solution
05/1984
05/30/1984EP0109683A2 New cephem compounds and processes for preparation thereof
05/29/1984EP0098291A4 Purification of tetrahydrodibenzo(b,d)pyrans from crude synthetic mixtures.
05/29/1984EP0096720A4 Process for the preparation of B-[(2-methylpropoxy)-methyl]-N-phenyl-N-(phenylmethyl)-1-pyrrolidineethanamine.
05/29/1984CA1168159A1 Oral compositions comprising hexetidine and zinc salts for the synergistic inhibition of dental plaque
05/24/1984WO1984001949A1 Cephalosporin derivatives, process and their preparation, and prophylactic and treating agent against bacterial infection
05/23/1984EP0109301A2 7-(S)-acylaminocephalosporin sulfones and process
05/23/1984EP0109294A2 Cephalosporin esters
05/23/1984EP0108942A2 Cephalosporin derivatives, methods of production thereof and prophylactic and therapeutic agents for bacterial infection
05/02/1984EP0107423A1 Novel chromans and chromenes
05/02/1984EP0107276A2 Novel form of cefuroxime ester, process for its preparation and composition containing it
05/01/1984US4446317 Cephalosporin antibiotics